Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02937623 · ClinicalTrials.gov registry record · NA
To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)
A NA study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT02937623 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 126 participants.
The verdict
NCT02937623, a NA study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
A proof of principle single-centre, randomized-controlled, examiner-blind, two treatment group study to investigate the efficacy of an experimental 15% w/w dissolvable strip in relieving dentine hypersensitivity (DH) after a single application and up to 4 hours after application compared to no treatment.
Interventions
- DEVICE Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2016-11-21 |
| Est. Completion | 2016-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02937623
The ClinicalTrials.gov registry entry for NCT02937623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate) is the first listed.
NCT02937623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02937623 about?
NCT02937623 is a clinical study titled "To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)". A proof of principle single-centre, randomized-controlled, examiner-blind, two treatment group study to investigate the efficacy of an experimental 15% w/w dissolvable strip in relieving dentine hypersensitivity (DH) after a single application and up to 4 hours after application compared to no treat...
What is the current status of trial NCT02937623?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2016-11-21. Estimated completion is 2016-12-22.
What interventions are being tested in trial NCT02937623?
The interventions under investigation include: Dissolvable polymer strip containing Novamin (calcium sodium phosphosilicate) (DEVICE).
Who is sponsoring clinical trial NCT02937623?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.